GSK 429286
Chemical Name: 4-[4-(Trifluoromethyl)phenyl]-N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide
Purity: ≥97%
Biological Activity
Selective Rho-kinase inhibitor (IC50 values are 14, 780 and 1940 nM for ROCK1, RSK and p70S6K respectively). Reverses adrenalin-induced contraction of the rat aortic ring (IC50 = 190 nM) and causes a dose-dependent decrease in mean arterial blood pressure in spontaneous hypertensive rats. Orally active.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
Development of dihydropyridone indazole amides as selective rho-kinase inhibitors.
Goodman et al.
J.Med.Chem., 2007;50:6 -
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease.
Nichols et al.
Biochem.J., 2009;424:47
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for GSK 429286
The citations listed below are publications that use Tocris products. Selected citations for GSK 429286 include:
2 Citations: Showing 1 - 2
-
RhoD Inhibits RhoC-ROCK-Dependent Cell Contraction via PAK6.
Authors: Durkin Et al.
Dev Cell 2017;41:315
-
Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma.
Authors: Qin Et al.
Cell 2017;170:845
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for GSK 429286
There are currently no reviews for this product. Be the first to review GSK 429286 and earn rewards!
Have you used GSK 429286?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
